Bausch + Lomb — Third Quarter 2026 Earnings Summary

Bausch + Lomb reported third-quarter 2026 revenue of $1.375 billion, representing a 7% increase from the prior year period. The company achieved GAAP net income of $32 million and adjusted EBITDA of $325 million, driven by strong growth across its Vision Care, Surgical, and Pharmaceuticals segments. Key product lines including MIEBO, LUMIFY, and the premium IOL portfolio contributed significantly to the revenue expansion. Consequently, Bausch + Lomb raised its full-year 2026 revenue guidance to a range of $5.450 billion to $5.550 billion and increased its adjusted EBITDA excluding acquired IPR&D guidance to $1.090 billion to $1.140 billion.